Results 291 to 300 of about 357,928 (304)

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

New England Journal of Medicine, 2017
Xavier Montalban, Ludwig Kappos, Douglas L Arnold   +2 more
exaly  

[Sciatica and multiple sclerosis (MS)].

Acta neurochirurgica, 1967
W, Ulbricht, H, Dietz
openaire   +1 more source

The multiple sclerosis market

Nature Reviews Drug Discovery, 2017
exaly  

FDA reversal sends mixed message to multiple sclerosis community

Nature Reviews Drug Discovery, 2014
exaly  

Multiple Sclerosis (MS)

openaire   +1 more source

Multiple Sclerosis (MS) Classification and Detection

2024 Intelligent Methods, Systems, and Applications (IMSA)
Youssef Hazem Mohamed Fathi Sharabas, Yasmine Abou Ouf Hamed, Zeinab Abd El Haliem Taha   +2 more
openaire   +1 more source

National Multiple Sclerosis Society (MS)

openaire   +2 more sources

0589 Cognition and Multiple Sclerosis (MS)

Journal of the Neurological Sciences, 2005
openaire   +1 more source

The history of multiple sclerosis (MS)

2007
John Zajicek, Jennifer Freeman, Bernadette Porter   +2 more
openaire   +1 more source

Multiple Sclerosis (MS), Basic Biology

2003
openaire   +1 more source